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Abstract
The ability to develop predictive mathematical models of therapeutic release from pharmaceutical
formulations has enormous potential to enhance our understanding of such systems and improve the
controlled release of the payload. The current work describes the development and testing of a one-
dimensional model of drug transport from amorphous, swelling/dissolving polymers. Model parameters such
as the diffusivities of water and drug, the initial loading of the drug, the polymer dissolution rate, drug-
polymer interactions, and the tablet thickness were varied, demonstrating the ability to tune the release to be
controlled by either drug diffusion or polymer chain disentanglement. In addition, predictions of the
concentration profiles of water and drug within the gel layer, the locations of the erosion and swelling
boundaries, and gel layer thickness were obtained for diffusion- and disentanglement-controlled release. To
highlight the generalizability of this model, multiple parameters were varied, and it was shown that increasing
the diffusivities of water and drug and the initial drug loading and decreasing the polymer dissolution rate
sufficiently resulted in diffusion-controlled release. The model was fit to experimental data for a model tablet
system comprising of sodium diclofenac entrapped in a poly(vinyl pyrrolidone) matrix and yielded physically
meaningful values of the model parameters. The work presented here demonstrates the predictive power of
the model for rapid and rational design of future pharmaceutical formulations for controlled drug delivery.
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Abstract
The ability to develop predictive mathematical models of therapeutic release from 
pharmaceutical formulations has enormous potential to enhance our understanding of 
such systems and improve the controlled release of the payload. The current work 
describes the development and testing of a one-dimensional model of drug transport from 
amorphous, swelling/dissolving polymers. Model parameters such as the diffusivities of 
water and drug, the initial loading of the drug, the polymer dissolution rate, drug-polymer 
interactions, and the tablet thickness were varied, demonstrating the ability to tune the 
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3release to be controlled by either drug diffusion or polymer chain disentanglement. In 
addition, predictions of the concentration profiles of water and drug within the gel layer, 
the locations of the erosion and swelling boundaries, and gel layer thickness were 
obtained for diffusion- and disentanglement-controlled release. To highlight the 
generalizability of this model, multiple parameters were varied, and it was shown that 
increasing the diffusivities of water and drug and the initial drug loading and decreasing 
the polymer dissolution rate sufficiently resulted in diffusion-controlled release. The model 
was fit to experimental data for a model tablet system comprising of sodium diclofenac 
entrapped in a poly(vinyl pyrrolidone) matrix and yielded physically meaningful values of 
the model parameters. The work presented here demonstrates the predictive power of 
the model for rapid and rational design of future pharmaceutical formulations for 
controlled drug delivery.
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The ability to develop predictive mathematical models to enhance our understanding of 
small molecule therapeutic release mechanisms from polymeric tablets and matrices is 
of paramount importance. Accurate and quantitative predictions of the characteristics of 
small molecule payloads released from polymer matrices will allow for rational a priori 
design of pharmaceutical drug-based formulations, resulting in both time and cost savings as 
well as the ability to tailor release kinetics based on desirable pharmacokinetic profiles. The 
sustained release of drugs from polymer-based tablets is a complex function of many parameters, 
including polymer concentration, drug loading, drug-polymer interactions, tablet dimensions, and 
dissolution media1. Over the past fifty years, there have been significant strides in our ability to 
understand drug release mechanisms of various polymer-based delivery systems, allowing for 
mathematical models and better design principles2–18. A predictive model that considers this 
enhanced understanding of physical phenomena during polymer dissolution and that accounts for 
all of the above parameters would not only better our understanding of the fundamental phenomena 
that govern drug release, but more importantly, provide a generalizable design tool that 
can be valuable to the pharmaceutical industry.
There are many well-studied mechanisms of drug release from polymeric matrices5,19,20, 
including: 1) Fickian diffusion from a porous polymer matrix; 2) diffusion following swelling 
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5of the polymer matrix; 3) release following swelling and subsequent dissolution of the 
polymer (either amorphous or semi-crystalline); and 4) erosion/degradation of the 
polymer matrix. The first two cases generally consider polymer matrices that are not 
soluble in a solvent, and therefore release of drug from the polymer matrix relies on a 
concentration gradient-driven Fickian diffusion of the drug through the matrix. Often times, 
however, the polymer matrix may be soluble in media, and there is now an increased 
understanding of all the phenomena that occur during polymer dissolution, based on both 
experimental advances as well as mathematical models1,10,15,16,20–26. Models that account 
for the swelling and subsequent dissolution of the polymer matrix are of particular interest 
because the interplay between the diffusive flux of drug and polymer dissolution rate can 
allow for tighter control over the release profile of drugs. 
This enhanced understanding of polymer dissolution has led to the design of models of drug 
release, which attempt to capture observable phenomena5,7–9,17,18,20,23,24,27,28, or more recently, 
statistical techniques, which attempt to develop quantitative structure-property relationships based 
upon experimental data29. Various models have been developed that take into account 
experimental conditions such as pH and ionic strength30, non-uniform drug distribution31, free 
volume32, and geometric effects33. Narasimhan and Peppas7 developed one of the first one-
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6dimensional models of drug release accounting for molecular level disentanglement mechanisms, 
based upon reptation theory. This model provided a quasi-steady state solution that could 
account for both diffusion- and disentanglement-controlled release and was validated with 
experimental data7. A focus of the current work is to extend the work of Narasimhan and 
Peppas by considering non-pseudo steady state solutions of drug release from 
swelling/dissolving amorphous polymers and validate the model predictions with 
experiments. The current model demonstrates the ability to accurately capture both 
diffusion- and disentanglement-controlled drug release, with control over parameters 
such as drug and water diffusivities, initial loading of drug, polymer dissolution rate, and 
equilibrium concentrations, therefore making it a valuable tool that can be employed for 
a priori design of pharmaceutical formulations.
Methods and Materials
Materials
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7Materials used for tablet fabrication and drug release experiments included sodium 
diclofenac, poly(vinyl pyrrolidone) (PVP; MW 40,000 Da and 360,000 Da) and cellulose 
acetate propionate, all of which were purchased from Sigma Aldrich (St. Louis, MO).
Tablet Preparation
A solid mixture of either 25% or 50% (w/w) sodium diclofenac in PVP (MW 40,000 Da or 
360,000 Da, depending on the system) was dissolved in isopropyl alcohol at a total solids 
concentration of 1 mg/mL. The solution was stirred until complete dissolution of the solids 
and the solution was dried in a vacuum oven. The dried product was then placed into a 
14 mm x 1 mm aluminum mold and pressed to approximately 258 psi on a Carver press 
(Model 4120, Wabash, IN). The tablets were coated on three sides with 15% (w/v) 
cellulose acetate propionate in acetone, which creates an impermeable barrier for water 
and reduces the dissolution of the tablet to one face of the tablet, leading to one-
dimensional transport. 
Polymer Dissolution and Drug Release
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8Tablet dissolution experiments were conducted in a 1-L USP dissolution apparatus 
(Hanson Research, Chatsworth, CA) at 37 °C in ultrapure water (Milli-Q Advantage A10, 
resistivity 18.2 MΩ, TOC ≤ 5 ppb), with a 25 RPM stir rate. Aliquots were collected at 1, 
10, 20, 30, 40, 50, 60, 70, 90, 120, 150, and 180 minutes and the released sodium 
diclofenac concentration was measured at 275 nm with a UV spectrophotometer 
(SpectraMax M3, Molecular Devices, San Jose, CA). The background optical density 
(OD) of nanopure water was subtracted from each sample’s OD measurement and the 
mass fraction of sodium diclofenac released was calculated as the OD at that specific 
time point divided by the OD of a sample following complete dissolution of the tablet. The 
experiments were performed in duplicate, with three tablets per formulation.
Model Description
The one-dimensional model of a drug-containing swelling/dissolving polymer tablet 
considers an amorphous polymer matrix in its glassy state prior to contact with solvent, 
with the drug uniformly distributed through the matrix (Figure 1A). Following initial contact 
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9with solvent, the portion of the polymer matrix that the solvent has penetrated into begins 
to relax and swell; this region is considered rubbery and is referred to as the gel layer of 
the polymer (Figure 1B). Solvent then continues to penetrate deeper into the glassy 
portion of the polymer matrix (as represented by the region between  and ) 𝑥 = 0 𝑥 = 𝑅
while the gel layer (as represented by the region between  and ) continues to 𝑥 = 𝑅 𝑥 = 𝑆
grow and expand outward, with the drug able to diffuse out of the swollen portion of the 
polymer and into the solvent. During this process, as the solvent continues to diffuse into 
the polymer, the polymer chains start disentangling. According to reptation theory34, at 
the swollen front, when the mobility of the polymer chains increases, the chains will 
disentangle by reptation and become free of the matrix after a characteristic time referred 
to as the reptation time ( ) and dissolve away from the bulk of the matrix and into the 𝑡𝑟𝑒𝑝𝑡
solvent. Once the polymer in the rubbery region begins to dissolve in the solvent, the 
swelling front ( ) begins to move inward. In the case of steady state dissolution, the 𝑥 = 𝑆
gel layer thickness ( ) will remain constant over this period until the glassy front (𝑆 ― 𝑅 𝑥 = 𝑅
) reaches the center of the tablet ( ). Once the solvent reaches the center of the tablet, 𝑥 = 0
the entire polymer matrix is rubbery and release of the drug from the tablet will be driven 
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by a combination of diffusion out of the polymer matrix and release following dissolution 
of the polymer matrix. 
Figure 1. Schematic representation of the swelling/dissolving polymer model. L is the 
thickness of the film/tablet. R is the thickness of the glassy front. S is the thickness of the 
swelling front.
There are two controlling mechanisms of drug release from swelling/dissolving polymer 
systems, namely drug diffusion- and polymer chain disentanglement-controlled 
release1,4,5,7. In the first case, diffusion-controlled release occurs when the diffusive flux 
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of drug is sufficiently high such that the release rate of drug is dominated by the diffusion 
of the drug out of the polymer matrix. This can occur through having higher diffusivities of 
drug (i.e., small molecule) and water or through increased loading of drug. In such 
systems, the Deborah number ( )35 can be used to describe the characteristics of 𝐷𝑒
solvent penetration into the polymer matrix, and thus the release of drugs from diffusion-
controlled systems. The  number is the ratio of chain relaxation time to solvent diffusion 𝐷𝑒
time into the polymer matrix; values of  << 1 or  >> 1 result in classical Fickian-like 𝐷𝑒 𝐷𝑒
diffusion while values of  ≈ 1 results in non-Fickian, anomalous diffusion. In the second 𝐷𝑒
case, disentanglement-controlled release occurs when either the polymer dissolution rate 
is sufficiently high, or the diffusivities of water and drug are low enough, such that the rate 
of polymer dissolution at the swelling front dictates the rate of release of drug from the 
polymer matrix. This could be the case for highly soluble polymers, polymers of low 
molecular weight, or larger payloads such as proteins, but can also occur when the initial 
loading of the payload is low such that the flux through the gel layer is less than that of 
the polymer dissolution rate. The current work describes the development and testing of 
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this one-dimensional model of drug transport from amorphous, glassy dissolving 
polymers using this phenomenological description. 
In previous work, Narasimhan and Peppas7 developed a pseudo steady state solution to 
the model equations, where the transport of water and drug through the gel layer was 
assumed to be at steady state throughout the entire release time period, resulting in linear 
concentration profiles through the gel layer as well as a linear increase in the gel layer 
thickness over time (in the case of disentanglement-controlled release). The current 
model does not make such assumptions, and hence the concentration profiles and gel 
layer thickness can exhibit non-linear profiles as a function of time.
This model considers three components, i.e., water (component ), polymer (component 1
), and drug (component ). The diffusion of drug and water are modeled according to 2 𝑑
Fick’s 2nd law of diffusion as follows:
Drug:  (1)
∂𝑣𝑑
∂𝑡 = ∂∂𝑥(𝐷𝑑∂𝑣𝑑∂𝑥 )
Water:  (2)
∂𝑣1
∂𝑡 = ∂∂𝑥(𝐷1∂𝑣1∂𝑥 )
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Here  is the volume fraction of either the drug (  = ) or water (  = ) and  is the 𝑣𝑖 𝑖 𝑑 𝑖 1 𝐷𝑖
diffusion coefficient of the drug or water. The polymer volume fraction can be obtained 
simply through:
(3)𝑣2 = 1 ― 𝑣𝑑 ― 𝑣1
The initial conditions for these mass balance equations are as follows:
(4a)@𝑡 = 0      ∀𝑥      𝑣1 = 0
(4b)@𝑡 = 0      ∀𝑥      𝑣𝑑 = 𝑣𝑑,0
(4c)@𝑡 = 0      ∀𝑥      𝑣2 = 𝑣2,0
Here,  and  are initial loading of drug and water, respectively. To satisfy the 𝑣𝑑,0 𝑣2,0
boundary conditions, a mass balance at the moving boundary representing the 
glassy/rubbery interface ( ) can be written as:𝑥 = 𝑅
(5)𝐹𝑜𝑟 𝑡 > 0:      (𝑣 ∗1 + 𝑣 ∗𝑑 )𝑑𝑅𝑑𝑡 = ― 𝐷1∂𝑣1∂𝑥 |𝑥 = 𝑅 ― 𝐷𝑑∂𝑣𝑑∂𝑥 |𝑥 = 𝑅
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Here  is the equilibrium concentration of water and  is the equilibrium concentration 𝑣 ∗1 𝑣 ∗𝑑
of drug at the glassy/rubbery front ( ). The initial condition for equation (5) is:𝑥 = 𝑅
(6)@𝑡 = 0      𝑅 = 𝑙
Here  is the initial half-thickness of the tablet, or thickness of the film. At the 𝑙
glassy/rubbery front ( ), the concentrations of water and drug can be determined by 𝑥 = 𝑅
free volume theory36. 
The other boundary condition exists at the swelling front, representing the rubbery/solvent 
interface, where  While , the swollen polymer matrix is still intact and since 𝑥 = 𝑆. 𝑡 < 𝑡𝑟𝑒𝑝𝑡
disentanglement is still ongoing, the polymer has not begun to dissolve into the solvent. 
Writing a mass balance at this front yields:
(7)0 < 𝑡 < 𝑡𝑟𝑒𝑝𝑡      (𝑣1,𝑒𝑞 + 𝑣𝑑,𝑒𝑞)𝑑𝑆𝑑𝑡 = 𝐷1𝑣1,𝑒𝑞∂𝑣1∂𝑥 |𝑥 = 𝑆 + 𝐷𝑑𝑣𝑑,𝑒𝑞∂𝑣𝑑∂𝑥 |𝑥 = 𝑆
However, once , disentanglement commences and the polymer chains at the 𝑡 = 𝑡𝑟𝑒𝑝𝑡
swollen front begin to dissolve into the solvent. The flux of the dissolving polymer into the 
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solvent is balanced by the rate of disentanglement of the polymer chains and can be 
described as follows:
(8)𝑡 > 𝑡𝑟𝑒𝑝𝑡      𝑥 = 𝑆 +     ― 𝐷2∂𝑣2∂𝑥 = 𝑘𝑑
Here  is the polymer chain disentanglement rate. According to Narasimhan and 𝑘𝑑
Peppas24, the polymer chain disentanglement rate can be calculated as:
(9)𝑘𝑑 = 𝑟𝑔𝑡𝑟𝑒𝑝𝑡
Here  is the radius of gyration of the polymer. Applying this condition to the swollen front 𝑟𝑔
for  yields:𝑡 > 𝑡𝑟𝑒𝑝𝑡
(10)𝑡 > 𝑡𝑟𝑒𝑝𝑡      (𝑣1,𝑒𝑞 + 𝑣𝑑,𝑒𝑞)𝑑𝑆𝑑𝑡 = 𝐷1𝑣1,𝑒𝑞∂𝑣1∂𝑥 |𝑥 = 𝑆 + 𝐷𝑑𝑣𝑑,𝑒𝑞∂𝑣𝑑∂𝑥 |𝑥 = 𝑆 + 𝑘𝑑
The initial condition for equation (10) is:
(11)@𝑡 = 0      𝑆 = 𝑙
At the swollen front, the equilibrium concentrations of the water and drug can be estimated 
using the Flory-Rehner equation for the temporarily swollen network formed by the chain 
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entanglements37, according to Narasimhan and Peppas7. These are all of the equations 
necessary to define the swelling and release of drug from the polymer matrix. One 
important point to note is that this model assumes perfect mixing, hence there are no 
mass transfer limitations beyond the gel-liquid interface (@ ).  𝑥 = 𝑆 +
The method to solving the two moving boundary Stefan problem is similar to that of Barry 
and Caunce38. This was done by first converting the moving boundaries to a fixed 
coordinate system by using a modified Landau transform:
(12)𝑧 = 𝑥 ― 𝑅𝑆 ― 𝑅
Therefore, even though R and S vary as a function of time,  can only range from 0 to 1. 𝑧
Taking the partial derivative of  with respect to time and  yields:𝑧 𝑥
(13)
∂𝑣𝑖
∂𝑥 = ∂𝑣𝑖∂𝑧 ∙ 1𝑆 ― 𝑅
(14)
∂𝑣𝑖
∂𝑡 = ∂𝑣𝑖∂𝑡 + ∂𝑣𝑖∂𝑧 ∂𝑧∂𝑡 = ∂𝑣𝑖∂𝑡 ― (𝑅′ + (𝑆′ ― 𝑅′) ∙ 𝑧)𝑆 ― 𝑅 ∂𝑣𝑖∂𝑧
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With the modified Landau transform, the diffusion equations and the boundary and initial 
conditions now take the following form:
(15)𝑫𝒓𝒖𝒈:∂𝑣𝑑∂𝑡 = 1(𝑆 ― 𝑅)2 ∂∂𝑧(𝐷𝑑∂𝑣𝑑∂𝑧 ) + (𝑅′ + (𝑆′ ― 𝑅′) ∙ 𝑧)𝑆 ― 𝑅 ∂𝑣𝑑∂𝑧
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 = 0      ∀𝑧      𝑣𝑑 = 𝑣𝑑,0
𝑅 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 0      𝑣𝑑 = 𝑣 ∗𝑑
𝑆 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 1      𝑣𝑑 = 𝑣𝑑,𝑒𝑞
(16)𝑾𝒂𝒕𝒆𝒓:∂𝑣1∂𝑡 = 1(𝑆 ― 𝑅)2 ∂∂𝑧(𝐷1∂𝑣1∂𝑧 ) + (𝑅′ + (𝑆′ ― 𝑅′) ∙ 𝑧)𝑆 ― 𝑅 ∂𝑣1∂𝑧
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 = 0      ∀𝑧      𝑣1 = 𝑣1,0
𝑅 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 0      𝑣1 = 𝑣 ∗1
𝑆 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 1      𝑣1 = 𝑣1,𝑒𝑞
(17)𝑷𝒐𝒍𝒚𝒎𝒆𝒓: 𝑣2 = 1 ― 𝑣1 ― 𝑣𝑑
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𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 = 0      ∀𝑧      𝑣2 = 𝑣2,0
𝑅 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 0      𝑣2 = 1 ― 𝑣 ∗𝑑 ― 𝑣 ∗1
𝑆 𝑏𝑜𝑢𝑛𝑑𝑎𝑟𝑦 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 > 0      𝑧 = 1      𝑣2 = 1 ― 𝑣𝑑,𝑒𝑞 ― 𝑣1,𝑒𝑞
𝑹 𝑩𝒐𝒖𝒏𝒅𝒂𝒓𝒚 𝑴𝒂𝒔𝒔 𝑩𝒂𝒍𝒂𝒏𝒄𝒆:𝑡 > 0      (𝑣 ∗1 + 𝑣 ∗𝑑 )𝑑𝑅𝑑𝑡 = ― 𝐷1𝑆 ― 𝑅∂𝑣1∂𝑧 |𝑧 = 0 ― 𝐷𝑑𝑆 ― 𝑅∂𝑣𝑑∂𝑧 |𝑧 = 0
(18)
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 = 0      𝑅 = 𝑙
𝑺 𝑩𝒐𝒖𝒏𝒅𝒂𝒓𝒚 𝑴𝒂𝒔𝒔 𝑩𝒂𝒍𝒂𝒏𝒄𝒆:0 < 𝑡 < 𝑡𝑟𝑒𝑝𝑡      (𝑣1,𝑒𝑞 + 𝑣𝑑,𝑒𝑞)𝑑𝑆𝑑𝑡 = 𝐷1𝑣1,𝑒𝑞𝑆 ― 𝑅 ∂𝑣1∂𝑧 |𝑧 = 1 ― 𝐷𝑑𝑣𝑑,𝑒𝑞𝑆 ― 𝑅 ∂𝑣𝑑∂𝑧 |𝑧 = 1
(19)
(20)𝑡 > 𝑡𝑟𝑒𝑝𝑡      (𝑣1,𝑒𝑞 + 𝑣𝑑,𝑒𝑞)𝑑𝑆𝑑𝑡 = 𝐷1𝑣1,𝑒𝑞𝑆 ― 𝑅 ∂𝑣1∂𝑧 |𝑧 = 1 + 𝐷𝑑𝑣𝑑,𝑒𝑞𝑆 ― 𝑅 ∂𝑣𝑑∂𝑧 |𝑧 = 1 + 𝐷2𝑆 ― 𝑅∂𝑣2∂𝑧 |𝑧 = 1
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛: 𝑡 = 0      𝑆 = 𝑙
An implicit backward Euler method was used to approximate the partial first derivatives 
of  with respect to time and position for the water and drug. A central difference equation 𝑣
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was used to approximate the partial second derivative of  with respect to position for 𝑣
water and drug. Following substitution of the algebraic approximations into the set of 
equations for the mass balances of drug, water, and the moving boundary equations, the 
set of equations were rearranged into a tridiagonal matrix and the Thomas algorithm39 
was used to solve for the concentration profile of drug, water, and polymer in the gel layer, 
the locations of the moving boundaries as a function of time, and the release profile for 
drug as a function of time. These model predictions were then tested by varying several 
parameters, including polymer molecular weight, chain disentanglement rate, drug 
diffusion coefficient, polymer-drug interactions, and the tablet dimensions. The 
predictions were also compared to experimental data on drug release rates for a model 
drug.
Results
The model was assessed for its ability to capture the characteristics of swelling of the 
polymer matrix and subsequent chain disentanglement (i.e., locations of the boundaries 
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 and , the gel layer thickness, concentration profiles of drug and water, and drug release 𝑅 𝑆
profile) for both disentanglement- (Figure 2) and diffusion- (Figure 3) controlled release 
of drug. First, the situation of disentanglement-controlled release was considered. As 
shown in Figure 2, the model demonstrates that at times just after water has contacted 
the glassy polymer matrix, an infinitesimally small gel layer is formed, with the 
concentration profile of drug and water across the gel layer being  and , 𝑣𝑑,0 𝑣1,0
respectively (Figure 2A and 2B, ). Very shortly thereafter, as water penetrates deeper 𝑡 = 0
into the gel layer (Figure 2C), a concentration profile begins to emerge within the gel layer, 
with the concentrations at the boundaries  and  rapidly reaching their equilibrium 𝑅 𝑆
concentrations (Figure 2A and 2B, ). The glassy front  begins to penetrate 𝑡/𝑡𝑓𝑖𝑛𝑎𝑙 = 0.05 𝑅
inward towards the center of the film (Figure 2C), while the swollen front  begins to swell 𝑆
outward (Figure 2D). Once the reptation time has elapsed, the polymer chains begin to 
dissolve into the water and the swollen front starts to move inward (Figure 2D). Depending 
on the dissolution rate of the polymer ( ) and the velocity of the glassy front, the gel layer 𝑘𝑑
thickness will either begin to shrink, continue to grow, or will reach a steady state, as is 
shown in Figure 2E. As time elapses, the normalized concentration profile of the drug and 
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water remain relatively unchanged (Figure 2A and 2B,  to ). This is 𝑡/ 𝑡𝑓𝑖𝑛𝑎𝑙 = 0.05 0.75
because the gel layer thickness is at a steady state, as well as the fact that the diffusivity 
of the drug is not high enough for diffusion through the gel layer. During this period, with 
a constant gel layer thickness, a sufficiently high polymer dissolution rate or low diffusivity 
of drug and water, the release of drug is controlled by the disentanglement rate of the 
polymer at the swollen front, resulting in zero-order release (Figure 2F). Once the glassy 
front has reached the center of the film, the entirety of the polymer matrix is the gel layer, 
and the release of drug is now dependent on a combination of drug diffusion and polymer 
dissolution at the swollen front. 
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Figure 2. Disentanglement-controlled release example of the swelling/dissolving polymer 
model. Model parameters used for this case were  = 1 mm, = 30 sec,  = -170 x 𝑙 𝑡𝑟𝑒𝑝𝑡 𝑘𝑑
10-8 m/s,  = 0.50,  = 0.25,  = 0.05,  = 0.30,  = 0.75,  = 4 x 10-10 m2/s, 𝑣𝑑,0 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1
and  = 2.5 x 10-10 m2/s. (A) Concentration profile of water through the gel layer over 𝐷𝑑
time, specifically 0, 5, 25, 50, 75, 90 and 99% of the release time frame. (B) Concentration 
profile of drug through the gel layer over time, specifically 0, 5, 25, 50, 75, 90 and 99% of 
the release time frame. (C) Location of the glassy front as a function of time. (D) Location 
of the swelling front as a function of time. (E) Thickness of the gel layer over time. (F) 
Mass fraction of drug released as a function of time.
A similar prediction can be made for the diffusion-controlled drug release situation (Figure 
3 A and B), however as shown in Figure 3F, the release of the drug is not controlled by 
the chain disentanglement rate because of the increased diffusivity of water and drug 
compared to the polymer dissolution rate. In this scenario, the gel layer thickness does 
not develop at a steady state thickness over the time period of the drug release. This is 
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because the increased diffusivity of water causes the glassy front to reach the center 
before a steady-state gel layer could be achieved (Figure 3C-E), hence allowing the drug 
to diffuse through the gel layer faster than the polymer can dissolve into the media, 
leading the drug to follow a square-root-of-time dependent release profile (Figure 3F). 
Therefore, the model demonstrates the expected characteristics of both disentanglement- 
and diffusion-controlled swollen/dissolving polymer systems, leading to different drug 
release profiles.
Figure 3. Diffusion-controlled release example of the swelling/dissolving polymer model. 
Model parameters used for this case were  = 1 mm,  = 30 sec,  = -25 x 10-8 m/s, 𝑙 𝑡𝑟𝑒𝑝𝑡 𝑘𝑑
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 = 0.50,  = 0.25,  = 0.05,  = 0.30,  = 0.75,  = 5 x 10-10 m2/s, and  = 3 𝑣𝑑,0 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1 𝐷𝑑
x 10-10 m2/s. (A) Concentration profile of water through the gel layer over time, specifically 
0, 5, 25, 50, 75, 90 and 99% of the release time frame. (B) Concentration profile of drug 
through the gel layer over time, specifically 0, 5, 25, 50, 75, 90 and 99% of the release 
time frame (C) Location of the glassy front as a function of time. (D) Location of the 
swelling front as a function of time. (E) Thickness of the gel layer over time. (F) Mass 
fraction of drug released as a function of time.
Parametric effects on model predictions
As previously mentioned, the model is able to account for multiple types of release profiles 
for drugs, i.e., diffusion-controlled or disentanglement-controlled. Therefore, multiple 
model parameters were systematically varied in order to demonstrate the ability of the 
model to account for all of these phenomena in different drug-polymer systems. These 
results are described next.
Diffusion-controlled vs. disentanglement-controlled drug release
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The model was tested for its ability to capture both diffusion-controlled and 
disentanglement-controlled release of the drug. The first case, diffusion-controlled 
release of drug, occurs when the diffusive flux of drug through the gel layer is greater than 
the dissolution rate of the polymer, either from an increased diffusivity of the drug and 
water or because of a high initial loading of the drug. Therefore, in order to account for 
these situations, conditions for diffusion-controlled release were first achieved for a set of 
model parameters and then the parameters , , , and  were varied in order to 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑
achieve disentanglement-controlled release of drug. As shown in Figure 4A, for a model 
system with an initial polymer dissolution rate of 25 x 10-8 m/s, an initial loading of 50% 
(v/v) drug, a water diffusivity of 5 x 10-10 m2/s, and a drug diffusivity of 3 x 10-10 m2/s (all 
reasonable values based on typical small molecule drug-based pharmaceutical tablet 
formulations), the release profile of drug demonstrated diffusion-controlled release (as 
demonstrated by fitting to a square-root-of-time dependence).
To achieve disentanglement-controlled release of drug, the model was first tested by 
decreasing the diffusivities of water and drug. When the diffusivities of drug and water 
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were decreased to 1 x 10-10 m2/s, the release profile became linear over the entire time 
period (Figure 4A). The same result was observed when the polymer dissolution rate was 
increased from 25 x 10-8 m/s to 120 x 10-8 m/s (Figure 4B), or when the initial loading of 
the drug was decreased from 50% to 15% (v/v) (Figure 4C). Therefore, the model is able 
to predict both diffusion- and disentanglement-controlled release of drugs, and the model 
parameters , , , and  were shown to be the most important in order to achieve 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑
the expected changes in the drug release profile. 
Effect of polymer molecular weight
As previously described23, the reptation time of the polymer is inversely correlated with 
the dissolution rate of the polymer. Therefore, in the case of disentanglement-controlled 
release for polymers with higher molecular weight, it should be expected that the polymer 
dissolution rate, and therefore the release rate of drug, should be slower compared to 
that of the same polymer of lower molecular weight. In order to test this hypothesis, model 
simulations were performed maintaining the same boundary conditions, and same values 
of , , , and  was varied in order to observe the effect on the rate of drug release. 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑
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As expected, decreasing  using values of 25 x 10-7 m/s, 15 x 10-7 m/s, and 10 x 10-7 𝑘𝑑
m/s resulted in a decrease in the rate of release of drug over time scales of 10, 20, and 
30 minutes, respectively (Figure 4D). Therefore, the model is able to accurately capture 
the effect of varying polymer molecular weight on the corresponding release kinetics of 
drugs from tablet formulations.
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Figure 4. Parametric variation of diffusion-controlled release to disentanglement-
controlled release by varying , , , and . (A) Case of decreasing water and drug 𝑘𝑑 𝐷1 𝐷𝑑 𝑣𝑑,0
diffusivities to  = 1 x 10-10 m2/s, and = 1 x 10-10 m2/s using diffusion-controlled release 𝐷1 𝐷𝑑 
parameters from Figure 3. (B) Case for increasing  to 125 x 10-8 m/s using diffusion-𝑘𝑑
controlled release parameters from Figure 3. (C) Case for decreasing initial loading of 
drug from 45% to 25% (w/w) for the following parameters:  = 1 mm,  = 30 sec,  = 𝑙 𝑡𝑟𝑒𝑝𝑡 𝑘𝑑
-9 x 10-8 m/s,  = 0.45,  = 0.15,  = 0.05,  = 0.45,  = 0.75,  = 1.4 x 10-10 𝑣𝑑,0 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1
m2/s, and  = 0.8 x 10-10 m2/s. (D) Case for decreasing  from 25 x 10-7 m/s to 10 x 10-7 𝐷𝑑 𝑘𝑑
m/s for the following parameters:  = 1 mm,  = 30 sec,  = 0.15,  = 0.10,  = 𝑙 𝑡𝑟𝑒𝑝𝑡 𝑣𝑑,0 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞
0.05,  = 0.13,  = 0.85,  = 1 x 10-10 m2/s, and  = 1 x 10-10 m2/s.𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1 𝐷𝑑
Effect of polymer-drug interactions
The rate of release of a drug from a polymer matrix is strongly dependent on miscibility 
of the drug within the polymer matrix. The miscibility of a drug within a polymer matrix is 
estimated by calculating the Flory-Huggins interaction parameter between the drug and 
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polymer, χd. The lower χd is (generally negative or slightly positive), the more likely the 
drug is miscible with the polymer and less likely it readily diffuses away into the 
surrounding medium40. Therefore, it is not surprising that, all things being equal, drug-
polymer systems with increased χd will have a lower , as can be shown with the Flory-𝑣𝑑,𝑒𝑞
Rehner equation, and therefore will have increased rate of release of drug due to an 
increased diffusive flux through the gel layer. This effect is accurately captured by the 
model, where  was decreased to simulate an increase in χd, and this led to an 𝑣𝑑,𝑒𝑞
increase in the rate of release of the drug as well as the curvature of the release profile 
over time (Figure 5A).
Effect of tablet dimensions
As this model is designed for cases of one-dimensional transport, it is able to account for 
changes in the thickness of the polymer matrix. This is shown in Figure 5B for the base 
case of disentanglement-controlled release (Figure 2), where increasing the thickness of 
the matrix from 1 mm to 5 mm increased the time period of release of the drug 
proportionally from 16 minutes to 80 minutes.
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Figure 5. Parametric variation of drug release by varying χd and . (A) Case of increasing 𝑙
χd demonstrated by decreasing  from 0.15 to 0.002 using the following parameters:  𝑣𝑑,𝑒𝑞 𝑙
= 1 mm,  = 30 sec,  = 25 x 10-8 m/s,  = 0.50,  = 0.25,  = 0.15,  = 0.30, 𝑡𝑟𝑒𝑝𝑡 𝑘𝑑 𝑣𝑑,0 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1
 = 0.75,  = 25 x 10-10 m2/s, and  = 10 x 10-10 m2/s. (B) Case of increasing  from 𝑣1,𝑒𝑞 𝐷1 𝐷𝑑 𝑙
1 mm to 5 mm for disentanglement-controlled release base case represented in Figure 
2.
Model validation
In order to validate the model, drug release experiments were performed using a model 
drug-polymer system. Release studies of sodium diclofenac were carried out with 14 mm 
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x 1 mm tablets comprising of either 25% or 50% (w/w) sodium diclofenac entrapped in a 
PVP matrix with a molecular weight of either 40,000 g/mol or 360,000 g/mol, and the 
experimentally measured drug release kinetics were compared to model predictions. The 
model was then compared to the experimental data by initially defining the boundary 
conditions and diffusivities of the water and drug, and the polymer dissolution rate was 
used as a fitting parameter. It is expected for this polymer-drug system that varying the 
initial loading of the drug will not change the diffusivities of the drug and water. Thus, the 
drug release rate will primarily depend on the initial loading of the drug and the polymer 
dissolution rate – for a higher molecular weight polymer,  will decrease, hence the 𝑘𝑑
release rate should also correspondingly decrease. 
The results shown in Figure 6 for the low molecular weight PVP tablets and in Figure 7 
for the high molecular weight PVP tablets indicate a good fit between the model and 
experimental data for both low and high initial loadings of sodium diclofenac. The release 
profiles for both the 25% and 50% sodium diclofenac in low molecular weight PVP tablets 
exhibited diffusion-controlled release (Figure 6). The data were fit by the model using  𝐷1
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= 4 x 10-10 m2/s,  = 4 x 10-10 m2/s, with  = -60 x 10-8 m/s for the 25% sodium diclofenac 𝐷𝑑 𝑘𝑑
tablet formulation or  = -80 x 10-8 m/s for the 50% sodium diclofenac tablet. For the high 𝑘𝑑
molecular weight tablets, a similar trend was observed with the higher loading of sodium 
diclofenac, however the 25% (w/w) sodium diclofenac tablet exhibited a linear release 
profile, indicating disentanglement-controlled release of the drug (Figure 7). This profile 
was also fit to the model using  = 0.5 x 10-10 m2/s, = 0.3 x 10-10 m2/s, and  = 12 x 𝐷1 𝐷𝑑 𝑘𝑑
10-8 m/s for the 25% sodium diclofenac tablet or  = 28 x 10-8 m/s for the 50% sodium 𝑘𝑑
diclofenac tablet. The results of the model in this work meaningfully represent the 
phenomena of polymer swelling and gel layer formation as described in experimental 
studies21,22,25. Additionally, values of , , , , , and equilibrium volume 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑 𝑡𝑟𝑒𝑝𝑡
fractions of drug, water, and polymer chosen to fit the experimental release data were 
consistent with ranges reported in the literature7,23,24,41–44. 
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Figure 6. Normalized mass fraction of sodium diclofenac released over time from low 
molecular weight (40,000 g/mol) PVP tablets containing (A) 25% (w/w) sodium diclofenac 
and (B) 50% (w/w) sodium diclofenac. Base conditions used for the model were  = 1 mm, 𝑙
 = 30 sec,  = 0.15,  = 0.05,  = 0.30,  = 0.85,  = 4 x 10-10 m2/s, and  𝑡𝑟𝑒𝑝𝑡 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1 𝐷𝑑
= 4 x 10-10 m2/s. Additional values used for the model were (A)  = 60 x 10-8 m/s,  = 𝑘𝑑 𝑣𝑑,0
0.22 and (B)  = 80 x 10-8 m/s,  = 0.46.𝑘𝑑 𝑣𝑑,0
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Figure 7. Normalized mass fraction of sodium diclofenac released over time from high 
molecular weight (360,000 g/mol) PVP tablets containing (A) 25% (w/w) sodium 
diclofenac and (B) 50% (w/w) sodium diclofenac. Base conditions used for the model 
were  = 1 mm,  = 300 sec,  = 0.15,  = 0.05,  = 0.30,  = 0.85,  = 0.5 x 𝑙 𝑡𝑟𝑒𝑝𝑡 𝑣 ∗𝑑 𝑣𝑑,𝑒𝑞 𝑣 ∗1 𝑣1,𝑒𝑞 𝐷1
10-10 m2/s, and  = 0.3 x 10-10 m2/s. Additional values used for the model were (A)  = 𝐷𝑑  𝑘𝑑
12 x 10-8 m/s,  = 0.22 and (B)  = 28 x 10-8 m/s,  = 0.46.𝑣𝑑,0  𝑘𝑑  𝑣𝑑,0
Discussion
The ability to accurately predict drug release kinetics from polymer matrices is an 
important component in the rational design of many pharmaceutical formulations; 
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understanding how the components of the formulation interact with each other as well as 
with the solvent can not only result in significant time and cost savings, but also provide 
more accurate control over the release of the drug payload. The model developed in this 
work extended the work of Narasimhan and Peppas7, in which a pseudo steady state 
approximation of the above presented set of equations was used to describe drug release 
from swelling/dissolving polymer-drug systems. Despite the ability of previous models to 
successfully explain experimental data, the model developed by Narasimhan and 
Peppas7 was the first to take into account a molecular level understanding of drug release 
from amorphous dissolving polymer based on reptation theory. In their pseudo steady 
state model, the concentration gradient through the gel layer was approximated as being 
linear, which was reasonable based upon the concentration gradients calculated in this 
work (Figure 2A and 2B). The gel layer thickness predictions in the pseudo steady state 
model were such that disentanglement-controlled release resulted in a linear release 
profile, with gel layer characteristics mimicking those shown in Figure 2. For diffusion-
controlled release, the release profile followed a square-root-of-time dependence with a 
linear increase in the gel layer thickness over time, similar to the scenario of diffusion-
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controlled release predicted by the current model (Figure 3), however the gel layer 
thickness tended to not increase linearly as the velocities of  and  were not constant, 𝑅 𝑆
as assumed in the pseudo-steady state model.
The current model was able to account for different types of drug release characteristics 
by systematic variation of model parameters. First, it was possible to demonstrate either 
diffusion- or disentanglement-controlled release of drug by varying , , , and . 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑
Increasing the initial loading of the drug and the diffusivities of water and drug resulted in 
diffusion-controlled release of the drug from the polymer matrix (Figure 4A and 4C); 
conversely, increasing the polymer dissolution rate led to linear release of drug (Fig 4B). 
In addition, the slope of the release of the drug was shown to be highly dependent on  𝑘𝑑
and . This is expected for both, as the rate of drug released from the polymer matrix 𝑣𝑑,0
is dependent on the rate of polymer dissolution in the case of disentanglement-controlled 
release, and increasing the initial loading of the drug would increase the concentration 
gradient, and thus the flux of drug through the gel layer1.
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There were a few observations from the experimental data that were taken into account 
in the model. As expected, an increase in the initial dose of the drug from 25% to 50% 
(w/w) led to a more rapid, and square-root-of-time release profile of the drug for both low 
and high molecular weight PVP tablets. This experimental observation was captured by 
the model, as increasing  led to a higher release rate of drug that mimicked the square-𝑣𝑑,0
root-of-time dependent release profile as indicated by the experimental data (Figures 6 
and 7). As the model would suggest, this could be due to the increased concentration 
gradient of drug in the gel layer, hence a higher rate of diffusion of the drug through the 
gel layer. Another expected trend observed was that the higher molecular weight PVP 
tablets (Figure 7) demonstrated prolonged release of the drug compared to the lower 
molecular weight PVP tablets (Figure 6), for both the 25% and 50% (w/w) drug loading. 
The model would suggest this could be due to a lower dissolution rate of the polymer, 
which is expected as  is inversely proportional to reptation time, and thus molecular 𝑘𝑑
weight. The model accurately captured this behavior because higher values of  were 𝑘𝑑
required for the low molecular weight PVP tablets than the high molecular weight PVP 
tablets to accurately fit the experimental data. In addition, values of the diffusivities of both 
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water and drug were lower for the higher molecular weight polymer compared to the lower 
molecular weight polymer tablets. This could be due to higher entanglement of the 
360,000 Da PVP, resulting in a reduced effective diffusion of water and drug through the 
gel layer.
The model can be employed for the purpose of simulating a variety of swelling/dissolving 
drug-polymer systems, including the choice of drug and polymer, for both diffusion- and 
disentanglement-controlled release. This can be accomplished by accounting for 
parameters such as the diffusivities of water and chosen drug, initial loading of the drug, 
polymer dissolution rate, polymer-drug interactions which would dictate the equilibrium 
concentrations at the  and  boundaries, and tablet dimensions, all of which are known 𝑅 𝑆
to dictate the drug release kinetics of experimental systems1. The ability of this model to 
capture the complex interplay between these parameters has the potential to be used for 
designing pharmaceutical formulations that provide controlled release of drug payloads. 
Further improvements to the model include accounting for excipients in the polymer 
matrix, polymer crystallinity, inhomogeneous drug distribution within the polymer matrix, 
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concentration-dependent diffusivity of water and drug, solubility of the drug in the solvent, 
mass transfer limitations at the boundary layer, and multi-dimensional transport.
Conclusions
Developing models that accurately predict the release kinetics of small molecule payloads 
from polymeric tablets would greatly enhance our understanding of polymer-payload 
systems and enable rapid optimization of such systems. In this work a new model of 
swelling/dissolution of polymeric matrices was developed that could demonstrate both 
diffusion- and disentanglement-controlled release of a small molecular weight drug 
payload. The model could account for changes in the diffusivities of the drug and water, 
the polymer molecular weight, the initial dose of the drug, polymer-drug interactions, and 
tablet dimensions, therefore enabling greater control over predicting the effect of these 
multivariate parameters on different types of observed drug release profiles. Finally, the 
model was fit to experimental data on drug release and demonstrated the ability to 
accurately fit the release data using meaningful , , , and  values, indicating its 𝑘𝑑 𝑣𝑑,0 𝐷1 𝐷𝑑
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value in terms of rationally (and rapidly) designing polymer-based pharmaceutical 
formulations for controlled drug delivery.
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